MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2022 International Congress

    A case of levodopa responsive parkinsonism due to methanol toxicity, an impact of COVID-19 crisis

    M. Shah, L. Patil, M. Bhatt (Mumbai, India)

    Objective: To report the clinical course of secondary parkinsonism due to methanol toxicity with good levodopa responsiveness in the background of COVID-19 crisis. Background: The…
  • 2022 International Congress

    Changes in the level of glial neurotrophic factor in Parkinson’s disease depending on the form

    B. Muminov, R. Matmurodov, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the form Background: Neurotrophic factors…
  • 2022 International Congress

    The Rostock International Parkinson’s Disease (ROPAD) Study: Analysis of Monogenic PD Genes

    A. Westenberger, V. Skrahina, C. Beetz, T. Usnich, E-J. Vollstedt, X. Bogdanovic, N. Schell, M. Olmedillas, F. Curado, J. Paul, S. Skobalj, N. Brüggemann, N. Ameziane, I. Csoti, M. Kasten, C. Klein, P. Bauer, A. Rolfs (Lübeck, Germany)

    Objective: The ROPAD study aims to investigate the frequency and spectrum of Parkinson’s disease (PD) genetic causes across a multitude of PD and other movement…
  • 2022 International Congress

    A PROSPECTIVE COHORT STUDY OF COGNITIVE IMPAIRMENT AND CORTISOL LEVELS IN PARKINSON’S DISEASE

    N. Soares, G. Pereira, A. Dutra, N. Artigas, J. Krimberg, B. Monticelli, A. Schumacher-Schuh, R. de Almeida, C. Rieder (Porto Alegre, Brazil)

    Objective: To assess cognitive impairment and cortisol levels in PD in a 14-month cohort study. Background: Cognitive impairment is one of the most common non-motor…
  • MDS Virtual Congress 2021

    Physical activity and cognitive functions in individuals with Parkinson’s disease

    APC. Loureiro, VL. Israel, B. Yamaguchi (Curitiba, Brazil)

    Objective: This study aimed to evaluate the relationship between physical activity and cognitive function in PD individuals. Background: Physical activity is positively associated with overall…
  • MDS Virtual Congress 2021

    Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study

    D. Dos Santos, D. Freire Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To evaluate the feasibility and identify obstacles in conducting teleconsultations for patients with parkinsonism in the Brazilian public health system Background: Patients with parkinsonism…
  • MDS Virtual Congress 2021

    Effect of Venglustat by GBA Mutation Severity in Patients With Parkinson’s Disease

    J. Peterschmitt, N. Giladi, R. Alcalay, G. Cutter, G. Höglinger, A. Schapira, C. Scherzer, T. Simuni, T. Gurevich, T. Gasser, C. Pacchetti, K. Marek, P. Minini, S. Sardi (Cambridge, USA)

    Objective: Report outcomes from Part 2 of the phase 2 MOVES-PD trial (NCT02906020) in patients with PD stratified by glucocerebrosidase (GBA) gene mutation severity. Background:…
  • MDS Virtual Congress 2021

    Causes of deaths in patients with Parkinson’s disease in the era before the use of modern drug therapy and at the present time

    S. Shtaimets (Omsk, Russian Federation)

    Objective: to study the impact of modern pharmacotherapy of Parkinson's disease (PD) on the main causes of death. Background: the modern era of the use…
  • MDS Virtual Congress 2021

    Hemiparkinsonism Due to Diencephalic Lesion with 24 Years of Levodopa Response and Only Mild Dyskinesia

    S. Filipović (Beograd, Serbia)

    Objective: To present a case of a long-standing hemiparkinsonism due to cerebral lesion with a continuous response to a stable dose of levodopa with only…
  • MDS Virtual Congress 2021

    A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson’s disease

    C. Fevga, Y. Park, E. Lohmann, A J. Kievit, G J. Breedveld, F. Ferraro, L. de Boer, R. van Minkelen, H. Hanagasi, A. Boon, W. Wang, G A. Petsko, Q Q. Hoang, M. Emre, V. Bonifati (Rotterdam, Netherlands)

    Objective: To report the identification of a novel variant in the gene encoding alpha-synuclein (SNCA), segregating with Parkinson’s Disease (PD) in two families of Turkish…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley